Team

There’s a lot of talk about the power of artificial intelligence and big data. A lot of talk, and a lot of promises.

Our team is grounded in experience and a track record of invention—realized. They have scaled technology businesses, fueled the adoption of new products among consumers, engaged people in their health online, and opened new markets by giving people information and tools to guide their health choices.

But our people are also grounded in the realities of what it means to push the bounds of science. They know biotech, omics, AI and data mining. They understand the complexity of molecular biology, what AI can and can’t do, and what it’s really like for people who live with and treat disease.

They’re not just talking about advancing the state of science. They’re focused on delivering real results for real people.

    Dr. Jun Wang Founder and Chief Executive Officer. Jun is responsible for the general management and business development of the company and a member of the Board of Directors. In 1999, Dr. Wang co-founded BGI, which is now widely recognized as one of world’s premier research facilities committed to excellence in genome sciences. During this time, Dr. Wang managed three rounds of fundraising (about 1B$ in total), and acquired a U.S. public company, Complete Genomics. He was recognized with numerous awards and nominations, such as His Royal Highness Prince Foundation, Nature’s 10 - the year in Science (2012), “Fortune’s 40 under 40” by Fortune Magazine (2013), “Highly Cited Researchers” (2013/2014/2015/2017) by Thomson Reuters (renamed Clarivate Analytics), “The 100 Most Creative People of 2017” by Fast Company. Dr. Wang earned a bachelor’s degree in artificial intelligence and a Ph.D. in bioinformatics from Peking University.
    Bill W. Colston

    President. Bill leads all of the operational and technology development functions at iCarbonX and is a member of the Board of Directors. Previously he served as Chief Executive Officer and Founder of HealthTell Inc™, a company focused on developing next generation tests that broadly characterize the immune system. Before that Bill was the CEO and Scientific Founder of QuantaLife Inc., a successful biotechnology startup company that developed a highly accurate genetic analysis system that is now sold internationally. Bill started his career working at Lawrence Livermore National Laboratory, where he served in various senior leadership roles over a nearly 20-year career and helped build the first civilian biodefense program in the United States. Bill is a board member of several companies, including Rheonix, Purigen, and RubrYc, and holds a Ph.D. in Biomedical Engineering from the University of California, Davis.

    Shawn Lee Chief Financial Officer. Shawn is responsible for the planning, implementing, managing and controlling all financial-related activities, including financial control, accounting, budgeting, investments and capital-raising. In addition, Shawn also assumes a strategic role in the management of the company. Prior to joining iCarbonX, Shawn was the Head of AEJ Healthcare Group for Goldman Sachs and has more than 10 years of investment banking experience. In that position he participated in multiple capital-raise through IPO and debt issuance, as well as in a wide variety of Mergers and Acquisitions of transactions in for Chinese and global healthcare companies. Shawn holds a Master’s degree in Business Administration from the University of Chicago Booth Business School, and Bachelor’s degrees in Economics and Biological Sciences from the University of Chicago.
  • Founder and Chief Executive Officer. Jun is responsible for the general management and business development of the company and a member of the Board of Directors. In 1999, Dr. Wang co-founded BGI, which is now widely recognized as one of world’s premier research facilities committed to excellence in genome sciences. During this time, Dr. Wang managed three rounds of fundraising (about 1B$ in total), and acquired a U.S. public company, Complete Genomics. He was recognized with numerous awards and nominations, such as His Royal Highness Prince Foundation, Nature’s 10 - the year in Science (2012), “Fortune’s 40 under 40” by Fortune Magazine (2013), “Highly Cited Researchers” (2013/2014/2015/2017) by Thomson Reuters (renamed Clarivate Analytics), “The 100 Most Creative People of 2017” by Fast Company. Dr. Wang earned a bachelor’s degree in artificial intelligence and a Ph.D. in bioinformatics from Peking University.
  • President. Bill leads all of the operational and technology development functions at iCarbonX and is a member of the Board of Directors. Previously he served as Chief Executive Officer and Founder of HealthTell Inc™, a company focused on developing next generation tests that broadly characterize the immune system. Before that Bill was the CEO and Scientific Founder of QuantaLife Inc., a successful biotechnology startup company that developed a highly accurate genetic analysis system that is now sold internationally. Bill started his career working at Lawrence Livermore National Laboratory, where he served in various senior leadership roles over a nearly 20-year career and helped build the first civilian biodefense program in the United States. Bill is a board member of several companies, including Rheonix, Purigen, and RubrYc, and holds a Ph.D. in Biomedical Engineering from the University of California, Davis.

  • Chief Financial Officer. Shawn is responsible for the planning, implementing, managing and controlling all financial-related activities, including financial control, accounting, budgeting, investments and capital-raising. In addition, Shawn also assumes a strategic role in the management of the company. Prior to joining iCarbonX, Shawn was the Head of AEJ Healthcare Group for Goldman Sachs and has more than 10 years of investment banking experience. In that position he participated in multiple capital-raise through IPO and debt issuance, as well as in a wide variety of Mergers and Acquisitions of transactions in for Chinese and global healthcare companies. Shawn holds a Master’s degree in Business Administration from the University of Chicago Booth Business School, and Bachelor’s degrees in Economics and Biological Sciences from the University of Chicago.